Clinical Trial Update: Matched Targeted Therapy For High-Risk Leukemias and Myelodysplastic Syndrome [NA]

View source ↗

Summary

An update on a matched targeted therapy trial for high-risk leukemias and myelodysplastic syndrome; results have been posted and the study is not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndrome

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Recurrent, Refractory, or High Risk Leukemias, Matched Targeted Therapy | NA | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-07-18